Serinus Biosciences YC Başvurusu

Summer 2022Active

Serinus Biosciences, Healthcare şirketi olarak Summer 2022 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.

YC grubu: Summer 2022
Sektör: HealthcareTherapeutics
Ekip büyüklüğü: 6
Durum: Active
Lansmanı Yapıldı: 2022

Kurucular

Adam YaariFounder/CEO
Maxwell ShermanFounder/CTO

Serinus Biosciences ne yapar

Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.

Serinus Biosciences'in YC başvurusu, yeniden yapılandırılmış

Y Combinator başvurusu

Serinus Biosciences, Summer 2022 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Serinus Biosciences

Describe what your company does in 50 characters or less.

Combinations therapy by rational design

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI platform that designs combination therapies to overcome cancer treatment resistance. Our system uses decades of system biology knowledge to model how cancer evolves escape routes to therapies, allowing us to propose molecule combinations that are more effective and safer. The output is explainable, letting researchers and clinicians understand why the selected combinations work.

Where do you live now, and where would the company be based after YC?

We live and operate in New York, NY, USA, and plan to keep the company based here after YC.

Explain your decision regarding location.

New York is a biotech and healthcare innovation hub with access to top academic partners and talent. Staying here lets us collaborate closely with our scientific advisors and prospective customers while benefiting from YC's remote-friendly approach.

Tam başvuruda 21 ek cevap

Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.

Tüm başvuruyu gör

Sıkça Sorulan Sorular

Bu, Serinus Biosciences şirketinin gerçek YC başvurusu mu?

Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, Serinus Biosciences'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. Serinus Biosciences gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.